Skip to content

A Study of the effects of a test-food on defecation

A Study of the effects of a test-food on defecation - A Study of the effects of a test-food on defecation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050544
Enrollment
40
Registered
2023-03-12
Start date
2023-03-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy men/female

Interventions

Ingestion of the test food (10 capsules a day) with water to the subjects for 4 weeks. Ingestion of the placebo food (10 capsules a day) with water to the subjects for 4 weeks. Ingestion of the placeb

Sponsors

Komazawa Women's University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy male/female subjects ranging in age from 50 to 100, at informed consent. (2)Persons who have received a full explanation of the study, understand its contents, and have given their written consent. (3)A person who understands the consent statement and obtains his/her signature

Exclusion criteria

Exclusion criteria: (1)Those who are currently receiving medication or outpatient treatment for various diseases that interfere with their daily life. (2)Those who are currently on a strict exercising or dieting under the supervision of a doctor (3)Subjects who may develop food allergies due to the test food (4)Those who have a current or a history of drug dependence or alcohol dependence (5)Those who are undergoing hospital visits for mental disorders (depression, etc.) or sleep disorders (insomnia, sleep apnea syndrome, etc.), or have a history of mental illness in the past (6)Subjects with significantly irregular life rhythms (eating, sleeping, extremely unbalanced diet, etc.) (7)Persons using drugs that affect immune function (8)Those who participated in other clinical trials (research) within 3 months before the date of consent acquisition, or those who plan to participate in other clinical trials (research) during the trial period (9)Those who are at risk of aspiration

Design outcomes

Primary

MeasureTime frame
Defecation status (the number of days, frequency, quantity, property, color, fecal odor, feeling of incomplete evacuation, abdominal swelling)

Secondary

MeasureTime frame
Physical condition(amount of food,sleep,skin,feeling,joint pain,cold hands and feet,swelling)

Countries

Japan

Contacts

Public ContactAtsushi Ohashi

Ebara Foods industry,Inc. Creative Division Research Institute

a.oohashi@ebarafoods.co.jp0465-85-5181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026